Invitae has inked a pair of deals to acquire Good Start Genetics and CombiMatrix, gaining a foothold in the prenatal screening arena.

Cantel Medical has agreed to acquire Germany's BHT Group, which markets automated endoscope processing technology.

Intermountain Health is the first health system to adopt Velano's PIVO technology, eliminating needle sticks from blood collection.

Roche will build digital services on Accenture’s platform, enabling it to pull in and analyze data to improve the management of diabetes.

EnteroMedics will modify its obesity-treating neuromodulation system for Galvani Bioelectronics to use in preclinical research.

Takeda and BioSurfaces are teaming up to create devices for the treatment of gastrointestinal disease based on the latter's nanofiber technology.

Personal genomics player Helix has launched an online marketplace for “DNA-powered products,” including Sema4's saliva-based carrier test from Sema4.

The latest deal sees Alere agree to sell its Epocal point-of-care blood diagnostic unit to Siemens for an undisclosed sum.

Voluntis picked up U.S. and EU nods to integrate Sanofi's Toujeo into its basal insulin management app and plans to add more.